Literature DB >> 3062604

Progressive hypokalaemia in elderly patients taking three thiazide potassium-sparing diuretic combinations for thirty-six months.

N Sawyer1, R Gabriel.   

Abstract

Three different thiazide potassium-sparing diuretic combinations were given to elderly patients for heart failure. Eighty patients received their allocated combinations for 3 years and had 6-monthly measurements of plasma potassium. A further 84 were recruited for study but 29 died within 6 months and 55 had to be withdrawn from the trial. The triamterene-containing preparation was discontinued most frequently (6/44) because of hypokalaemia (plasma potassium less than 3.0 mmol/l); amiloride (5/44) and spironolactone (1/47). The median fall in plasma potassium over 3 years in those patients not withdrawn because of hypokalaemia was similar in each case (P greater than 0.05) and possibly failed to reach significance because of the withdrawal rate (9%). The trend was for a greater fall in those patients taking triamterene. The spironolactone-containing preparation may be the least unsatisfactory of the three.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3062604      PMCID: PMC2428868          DOI: 10.1136/pgmj.64.752.434

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  A comparison of the properties of chlorothiazide, spironolactone and a combination of both as diuretic agents.

Authors:  D A OGDEN; L SCHERR; N SPRITZ; A L RUBIN
Journal:  N Engl J Med       Date:  1961-08-24       Impact factor: 91.245

2.  Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.

Authors:  C F George; A M Breckenridge; C T Dollery
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

3.  Amiloride. A potassium-sparing natriuretic agent.

Authors:  M B Bull; J H Laragh
Journal:  Circulation       Date:  1968-01       Impact factor: 29.690

Review 4.  The cardiovascular risks of thiazide diuretics.

Authors:  E D Freis
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

5.  Malignant hyperkalaemia after amiloride/hydrochlorothiazide treatment.

Authors:  L Jaffey; A Martin
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

6.  A study of two diuretic/potassium combinations in heart failure.

Authors:  M Hussain; K Walton; C Davidson; D B Morgan
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

7.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

8.  Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.

Authors:  T B Cocke; S Fisch; H R Gilmore; R Okun; I G Tamagna; K Wipplinger
Journal:  J Clin Pharmacol       Date:  1977 May-Jun       Impact factor: 3.126

9.  Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.

Authors:  L E Ramsay; J Hettiarachchi; R Fraser; J J Morton
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

10.  Hypokalaemia and diuretics: an analysis of publications.

Authors:  D B Morgan; C Davidson
Journal:  Br Med J       Date:  1980-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.